influenza
viru
iav
enter
host
cell
upon
bind
hemagglutinin
glycoprotein
sialyl
host
cell
receptor
wherea
dynamindepend
clathrinmedi
endocytosi
cme
gener
consid
iav
infect
pathway
observ
suggest
occurr
yet
uncharacter
altern
entri
rout
manipul
entri
paramet
establish
experiment
condit
allow
separ
analysi
dynamindepend
independ
entri
iav
wherea
entri
iav
phosphatebuff
salin
could
complet
inhibit
dynasor
specif
inhibitor
dynamin
dynasoreinsensit
entri
pathway
becam
function
presenc
fetal
calf
serum
find
confirm
use
small
interf
rna
target
presenc
serum
iav
entri
pathway
oper
condit
entri
could
fulli
block
combin
treatment
dynasor
amilorid
deriv
eipa
hallmark
inhibitor
macropinocytosi
wherea
either
drug
alon
effect
sensit
dynaminindepend
entri
pathway
inhibitor
dominantneg
mutant
affect
actomyosin
dynam
well
number
specif
inhibitor
growth
factor
receptor
tyrosin
kinas
downstream
effector
thereof
point
involv
macropinocytosi
iav
entri
consist
iav
particl
solubl
fitcdextran
shown
coloc
cell
vesicl
thu
addit
classic
dynamindepend
clathrinmedi
endocytosi
pathway
iav
enter
host
cell
dynaminindepend
rout
characterist
macropinocytosi
citat
de
vri
e
tschern
dm
wienholt
mj
v
scholt
f
et
al
dissect
influenza
viru
endocyt
rout
reveal
macropinocytosi
altern
entri
pathway
plo
pathog
influenza
viru
iav
envelop
segment
negativestrand
rna
viru
infect
wide
varieti
bird
mammal
first
step
infect
iav
attach
host
cell
bind
major
surfac
protein
hemagglutinin
ha
sialic
acid
omnipres
glycolipid
glycoprotein
expos
surfac
cell
structur
requir
interact
studi
great
detail
much
less
known
whether
attach
specif
sialyl
receptor
eg
nlink
glycoprotein
olink
glycoprotein
gangliosid
even
specif
receptor
within
group
affect
subsequ
endocyt
step
obvious
knowledg
repertoir
endocyt
pathway
success
use
iav
increas
insight
cell
speci
tropism
iav
turn
contribut
understand
requir
gener
novel
virus
pandem
potenti
aris
exchang
rna
segment
current
circul
human
serotyp
anim
viru
occasion
coinfect
human
anim
host
clathrin
mediat
endocytosi
cme
long
identifi
studi
major
rout
iav
cell
entri
far
best
character
endocyt
pathway
evid
obtain
live
cell
imag
reveal
de
novo
format
clathrinco
pit
site
viru
attach
requir
adapt
protein
epsin
process
still
specif
transmembran
receptor
link
viral
entri
epsin
adapt
identifi
although
recent
studi
perform
cho
cell
indic
specif
requir
nlink
glycoprotein
iav
entri
recent
paper
provid
indic
util
altern
entri
pathway
iav
studi
cme
obstruct
pharmacolog
genet
intervent
indic
abil
iav
enter
host
cell
via
altern
endocyt
rout
also
live
cell
imag
reveal
simultan
avail
entri
rout
involv
noncoat
well
clathrinco
pit
howev
altern
iav
entri
rout
character
detail
requir
specif
receptor
usag
apart
need
proper
sialic
acid
moieti
establish
past
decad
quit
varieti
endocyt
pathway
identifi
eukaryot
cell
occurr
abund
mechanist
detail
appear
vari
cell
type
tissu
speci
util
virus
rout
entri
make
import
factor
host
celltyp
permiss
infect
besid
cme
differ
virus
shown
enter
cell
via
caveola
macropinocytosi
less
well
describ
rout
often
select
specif
endocyt
rout
link
util
specif
receptor
facilit
travel
via
particular
rout
nevertheless
mani
receptor
allow
flexibl
capac
enter
multipl
pathway
iav
addit
level
complex
dissect
potenti
entri
rout
ad
appar
lack
iavspecif
protein
receptor
full
experiment
character
iav
entri
pathway
benefit
separ
iav
entri
pathway
rout
studi
independ
wherea
coloc
clathrin
establish
marker
endocytosi
via
rout
complet
lack
uniqu
marker
macropinosom
endocyt
compart
complic
studi
furthermor
crucial
studi
concern
endocyt
pathway
abundantli
document
fact
pathway
highli
depend
experiment
cell
cultur
condit
pathway
constitut
one
cell
type
may
absent
induc
specif
experiment
condit
cell
type
moreov
manipul
specif
endocyt
pathway
may
result
regul
specif
pathway
establish
entri
assay
condit
allow
dissect
cell
entri
iav
dynamindepend
dynadep
dynaminindepend
dynaind
compon
dynamin
larg
gtpase
form
multimer
assembl
around
neck
newli
form
endocyt
vesicl
gtp
hydrolysi
requir
pinch
vesicl
wherea
cme
complet
depend
dynamin
sever
endocyt
rout
requir
dynamin
perform
extens
character
dynaminindepend
iav
entri
rout
use
pharmacolog
inhibitor
well
express
dominantneg
mutant
appli
sirna
induc
gene
silenc
tool
taken
togeth
result
identifi
pathway
close
resembl
macropinocytosi
novel
entri
pathway
iav
identifi
character
potenti
noncm
entri
rout
taken
iav
adapt
luciferas
report
assay
enabl
quantit
determin
infect
entri
measur
activ
secret
gaussia
luciferas
twentyfour
hour
prior
infect
hela
cell
transfect
plasmid
phhgluc
allow
constitut
synthesi
driven
human
poli
promot
neg
strand
viral
rna
vrna
encod
gaussia
luciferas
control
untransl
region
utr
np
segment
influenza
hereaft
call
iavwsn
np
segment
upon
iav
infect
combin
express
viral
polymeras
subunit
np
drive
transcript
luciferas
mrna
neg
strand
vrna
subsequ
synthesi
gaussia
luciferas
doserespons
curv
demonstr
applic
assay
inhibitor
screen
fig
obtain
bafilomycin
known
inhibitor
iav
entri
act
upon
vacuolartyp
h
atpas
thu
prevent
endosom
acidif
therebi
trap
iav
perinuclear
immatur
endosom
lumen
ph
permit
viral
membran
fusion
remark
dynasor
small
molecul
inhibitor
gtpase
dynamin
crucial
endocyt
vesicl
format
clathrinand
caveolinmedi
endocytosi
well
poorli
describ
clathrinand
caveolinindepend
endocyt
pathway
give
signific
inhibit
fig
specif
inhibit
iav
entri
phase
demonstr
fig
continu
presenc
nm
ad
cell
hr
prior
infect
hr
complet
prevent
infect
contrast
addit
hr
hr
post
infect
result
high
level
luciferas
activ
measur
hr
pi
respect
control
ad
indic
entri
essenti
complet
within
hr
last
bar
fig
show
inhibit
revers
withdraw
inhibitor
hr
result
high
level
infect
specif
effect
iav
entri
confirm
confoc
microscopi
demonstr
expect
trap
iav
particl
perinuclear
locat
presum
nonacidifi
endosom
fig
subsequ
exploit
establish
specif
iav
entri
assay
hereaft
refer
glucentri
assay
hela
cell
transfect
phhgluc
inocul
iav
rang
moi
incub
hr
entri
medium
replac
complet
growth
medium
contain
fc
nm
prevent
entri
viru
entri
indirectli
quantifi
determin
luciferas
activ
incub
hr
demonstr
quantit
correl
infect
dose
luciferas
activ
across
wide
rang
moi
fig
indirect
glucentri
assay
next
test
capac
examin
effect
inhibitor
iav
entri
dynasor
fig
includ
medium
dmem
contain
attach
entri
host
cell
first
crucial
step
establish
success
viru
infect
critic
factor
determin
host
cell
speci
tropism
influenza
viru
iav
attach
host
cell
bind
major
surfac
protein
hemagglutinin
sialic
acid
omnipres
glycolipid
glycoprotein
expos
surfac
cell
iav
subsequ
enter
cell
bird
wide
varieti
mammal
via
receptormedi
endocytosi
use
clathrin
well
via
altern
uncharacter
rout
elucid
endocyt
pathway
taken
iav
hamper
appar
redund
establish
product
infect
manipul
entri
condit
establish
experiment
set
allow
separ
analysi
dynamindepend
includ
clathrinmedi
endocytosi
independ
entri
iav
collect
result
indic
macropinocytosi
main
rout
nonselect
uptak
extracellular
fluid
cell
altern
iav
entri
rout
dynamindepend
independ
iav
entri
rout
redund
independ
separ
manipul
crucial
identif
character
altern
iav
entri
rout
similar
strategi
might
applic
studi
endocyt
pathway
taken
virus
fc
entri
first
h
infect
remov
inoculum
replac
growth
medium
contain
concentr
mm
dynasor
inhibit
entri
agreement
result
shown
fig
contrast
nm
alreadi
inhibit
entri
fig
control
dynasor
also
ad
hr
post
infect
analyz
whether
drug
affect
iav
replic
post
entri
phase
expect
mm
dynasor
significantli
inhibit
iav
replic
present
hr
pi
fig
thu
glucentri
assay
studi
effect
specif
inhibitor
iav
entri
quantit
manner
least
long
inhibitor
irrevers
affect
iav
replic
post
entri
phase
furthermor
lack
inhibit
iav
entri
dynasor
demonstr
experiment
condit
iav
abl
enter
cell
via
pathway
fulli
redund
dynamindepend
dynadep
entri
rout
includ
classic
cme
pathway
also
iav
travel
via
novel
dynaminindepend
dynaind
rout
iav
appar
enter
via
low
ph
compart
entri
fulli
sensit
factor
present
serum
known
potenti
induc
specif
endocyt
pathway
explor
condit
requir
novel
dynaind
iav
entri
pathway
use
glucentri
assay
inocul
cell
pb
presenc
increas
concentr
fetal
calf
serum
fc
wherea
dynasor
complet
inhibit
entri
pb
inclus
fc
result
increas
level
dynasor
resist
entri
fig
suggest
exist
seruminduc
dynaind
iav
entri
pathway
effect
caus
inactiv
dynasor
experi
vesicular
stomat
viru
vsv
enter
cell
cme
still
sensit
mm
dynasor
presenc
fc
fig
agreement
herewith
uptak
transferin
known
occur
via
cme
inhibit
dynasor
regardless
hela
cell
grown
glass
cover
slip
infect
iav
strain
wsn
moi
fixat
min
hr
hr
column
respect
infect
perform
dmso
upper
row
panel
presenc
nm
lower
row
panel
nucleu
visual
dna
stain
red
iav
infect
visual
stain
monoclon
antiserum
direct
np
green
absenc
inhibitor
iav
local
nucleu
hr
new
viru
particl
spread
cytoplasm
hr
lower
row
panel
caus
accumul
incom
viru
particl
perinuclear
locat
e
quantit
determin
iav
entri
singlecycl
glucentri
assay
hela
cell
cellswel
dmem
supplement
fc
transfect
phhgluc
hr
prior
infect
serial
dilut
infecti
iav
particl
plot
xaxi
two
hour
infect
nm
ad
block
entri
cell
incub
hr
allow
express
luciferas
activ
yaxi
rel
light
unit
rlu
f
effect
dynasor
iav
entri
glucentri
assay
dynasor
dy
dark
grey
bar
mm
light
grey
bar
nm
present
hr
prior
infect
strain
wsn
moi
hr
pi
inhibitorcontain
medium
replac
medium
contain
nm
block
entri
cell
incub
hr
allow
quantit
express
luciferas
activ
yax
rlu
rel
control
infect
without
inhibitor
wherea
display
dosedepend
inhibit
iav
entri
dynasor
significantli
inhibit
iav
entri
presenc
fc
fig
panel
expect
dynadep
entri
pb
dynaind
entri
presenc
fc
mm
dynasor
requir
sialic
acid
receptor
effici
entri
pretreat
hela
cell
neuraminidas
almost
complet
abolish
entri
via
either
pathway
fig
kinet
dynadep
dynaind
entri
pathway
compar
perform
timecours
experi
iav
entri
termin
addit
nm
differ
time
point
fig
comparison
entri
via
dynadep
pathway
pathway
avail
pb
entri
presenc
fc
presum
dynadep
dynaind
entri
pathway
avail
show
similar
kinet
contrast
entri
via
dynaind
pathway
pathway
activ
presenc
fc
mm
dynasor
slower
differ
promin
min
hr
similar
level
entri
reach
valid
extend
result
visual
reduct
number
infect
cell
immunoperoxidas
stain
use
antibodi
np
fig
number
differ
cell
mammalian
avian
origin
infect
hour
moi
pb
without
serum
hour
inoculum
replac
growth
medium
contain
fc
nm
express
np
examin
hour
later
incub
pb
stain
complet
prohibit
presenc
mm
dynasor
wherea
presenc
serum
dynasor
effect
seruminduc
dynaind
rout
entri
thu
function
five
cell
line
includ
human
epitheli
airway
carcinoma
cell
line
confirm
result
obtain
proof
util
dynadep
dynaind
entri
rout
iav
addit
use
iav
viruslik
particl
vlp
direct
entri
assay
vlp
contain
iav
ha
na
envelop
harbor
betalactamas
report
protein
fuse
influenza
matrix
allow
rapid
direct
detect
entri
independ
viru
replic
upon
fusion
viral
endosom
membran
gain
access
cytoplasm
retain
fluorigen
substrat
cleavag
shift
shorter
fluoresc
emiss
wavelength
detect
flow
cytometri
entri
hela
cell
perform
absenc
presenc
fc
use
vlp
contain
ha
na
either
iavwsn
strict
alpha
link
sialic
acid
bind
specif
pandem
iav
ha
bind
alpha
alpha
link
sialic
acid
na
entri
vlp
iav
strain
sever
inhibit
dynasor
serum
ad
inoculum
fig
wherea
presenc
fc
render
entri
complet
dynasor
resist
fig
quantif
vlp
entri
shown
fig
f
importantli
confirm
exist
seruminduc
entri
pathway
method
independ
dynasor
use
sirna
induc
silenc
dynamin
fig
show
two
differ
sirna
signific
inhibitori
effect
hr
sirna
transfect
entri
renilla
luciferaseencod
pseudoviru
wsnren
hela
cell
absenc
fc
wherea
presenc
serum
reduct
entri
level
observ
confirm
result
obtain
dynasor
knockdown
dynamin
protein
level
hr
sirna
transfect
analyz
western
conclud
dynaind
entri
pathway
induc
serum
differ
cell
type
sever
speci
evid
obtain
use
replicationdepend
glucentri
assay
immunodetect
infect
cell
replicationindepend
assay
entri
vlp
latter
allow
immedi
detect
fusionmedi
deliveri
viral
protein
cytoplasm
cascad
blue
histogram
entri
display
shift
higher
fluoresc
grey
area
repres
background
fluoresc
noninfect
cell
c
f
quantif
fac
result
background
fluoresc
subtract
measur
geometr
mean
data
normal
vlp
entri
optimem
without
dynasor
dy
red
curv
panel
vlp
entri
inhibit
dynasor
presenc
fc
wherea
access
substrat
cytoplasm
block
dynasor
pb
vlp
entri
effici
presenc
serum
g
effect
downregul
dynamin
sirna
silenc
seruminduc
dynaind
entri
analyz
hela
cell
transfect
hr
prior
infect
two
differ
sirna
target
dyna
sirna
treat
cell
infect
pseudoviru
wsnren
pb
grey
bar
pb
contain
fc
black
bar
luciferas
activ
determin
hr
post
infect
yaxi
rlu
rel
infect
cell
transfect
scrambl
sirna
entri
pseudoviru
wsnren
moi
reduc
entri
perform
pb
grey
bar
wherea
entri
significantli
affect
presenc
serum
black
bar
h
western
blot
show
knockdown
dynamin
comparison
tubulin
hr
transfect
sirna
quantif
residu
level
dynamin
dyna
mrna
determin
quantit
rtpcr
protein
determin
densitometr
scan
western
blot
hr
sirna
transfect
data
normal
rna
rtpcr
tubulin
protein
level
calcul
rel
level
obtain
transfect
scrambl
sirna
serv
control
inhibitor
growth
factor
receptor
tyrosin
kinas
actomyosin
network
dynam
reduc
dynaind
entri
iav
dynaind
entri
pathway
character
inhibitor
profil
use
kinas
inhibitor
librari
seruminduc
dynaind
entri
examin
fc
use
glucentri
assay
mm
dynasor
ad
order
block
cme
potenti
dynadep
entri
pathway
allow
independ
inhibitor
profil
novel
pathway
avoid
potenti
mask
effect
presenc
redund
entri
pathway
cell
preincub
kinas
inhibitor
mm
h
inocul
viru
moi
presenc
fc
mm
dynasor
h
dynaind
entri
parallel
inocul
also
done
pb
compar
effect
inhibitor
dynadep
entri
hr
medium
inhibitor
replac
full
growth
medium
contain
fc
nm
allow
subsequ
express
gluc
activ
ident
condit
dynaind
depend
entri
assay
six
kinas
inhibitor
appear
act
nondiscrimin
inhibit
dynadep
dynaind
entri
fig
protein
kinas
c
pkc
inhibitor
ro
rottlerin
display
moder
cytotox
result
shown
hypericin
three
previous
identifi
iav
inhibitor
highli
cytotox
panspecif
serinethreonin
proteas
inhibitor
staurosporin
irrevers
kinas
inhibitor
wortmannin
receptor
tyrosin
kinas
inhibitor
order
investig
whether
inhibitor
affect
iav
replic
postentri
phase
perform
experi
ad
kinas
inhibitor
viral
entri
four
inhibitor
thu
appear
induc
signific
inhibit
postentri
process
fig
although
unlik
formal
exclud
postentri
process
specif
one
two
entri
pathway
affect
interestingli
wherea
specif
dynadep
entri
inhibitor
identifi
inhibitor
none
display
cytotox
effect
data
shown
caus
signific
inhibit
dynaind
entri
fig
includ
inhibitor
calmodulin
depend
kinas
myosin
light
chain
kinas
mlck
camkii
seven
inhibitor
differ
growth
factor
receptor
tyrosin
kinas
contrast
three
nonspecif
pkc
inhibitor
mention
pkc
inhibitor
hbdde
appear
specif
inhibitori
effect
dynaind
entri
specif
effect
drug
dynaind
entri
shown
lack
inhibit
dynadep
entri
pb
also
observ
none
fifteen
compound
induc
inhibit
ad
postentri
hr
post
infect
kinas
librari
screen
repeat
human
epitheli
lung
carcinoma
cell
order
confirm
result
potenti
natur
host
cell
line
inhibit
profil
obtain
similar
found
hela
cell
except
strong
effect
inhibit
moder
effect
inhibit
inhibit
dynadep
entri
fig
mlck
inhibitor
report
highli
specif
target
kinas
phosphoryl
mlck
activ
nonmuscl
myosin
ii
light
chain
indic
function
actomyosin
network
might
essenti
dynaind
entri
iav
examin
test
effect
blebbistatin
inhibitor
myosin
ii
heavi
chain
activ
sever
inhibitor
affect
actin
dynam
disrupt
actin
microfila
cytochalasin
b
enhanc
actin
polymer
jasplakinolid
inhibit
actin
polymer
latrunculin
actin
inhibitor
use
minim
concentr
requir
induc
clearli
visibl
chang
actin
cytoskeleton
predetermin
stain
fitcphalloidin
result
shown
wherea
inhibitor
affect
dynadep
entri
fig
use
glucentri
assay
inhibitor
well
significantli
inhibit
dynaind
entri
fig
next
hela
cell
transfect
plasmid
encod
domin
neg
wildtyp
fuse
green
fluoresc
protein
dn
wt
fig
h
prior
infect
iav
small
gtpase
found
associ
sever
endosom
compart
crucial
function
matur
earli
endosom
requir
traffick
wide
rang
endocyt
cargo
follow
differ
rout
includ
dynadep
well
dynaind
rout
entri
iav
shown
requir
consist
found
hela
cell
express
dn
identifi
gfp
fluoresc
fig
much
less
suscept
product
iav
infect
judg
indirect
immunofluoresc
use
label
np
antibodi
cell
transfect
sever
dynaminindepend
endocyt
pathway
describ
macropinocytosi
demonstr
stimul
growth
factor
present
serum
depend
actin
dynam
yet
studi
macropinocytosi
hamper
lack
specif
inhibitor
cargo
membran
marker
characterist
morpholog
amilorid
potent
deriv
eipa
inhibitor
epitheli
sodium
channel
enac
well
sever
nah
antiport
eipa
often
use
hallmark
inhibitor
specif
inhibit
endocytosi
via
macropinocyt
pathway
wherea
dynadep
entri
iav
inhibit
eipa
fig
dynaind
entri
fulli
block
eipa
fig
exist
redund
entri
pathway
presenc
fc
clearli
demonstr
margin
inhibit
either
eipa
dynasor
wherea
combin
eipa
dynasor
result
strong
inhibit
glucentri
assay
fig
direct
vlp
entri
assay
fig
e
supplementari
fig
show
cell
line
includ
human
lung
epitheli
cell
line
display
similar
iav
inhibit
pattern
eipa
dynasor
consist
viru
product
display
similar
inhibitor
sensit
profil
f
g
viru
entri
indic
entri
pathway
character
lead
product
infect
clearli
vlp
viral
particl
follow
similar
redund
entri
pathway
distinguish
dynadep
dynaind
pathway
latter
sensit
eipa
depend
actomyosin
function
one
characterist
macropinocytosi
nonselect
uptak
larg
amount
extracellular
solut
therefor
uptak
solubl
fitc
label
dextran
fdx
rel
larg
vesicl
mm
often
appli
morpholog
marker
macropinosom
use
marker
found
addit
fc
cultur
medium
slightli
increas
uptak
fdx
hela
cell
fig
notabl
distribut
fdx
chang
respons
serum
random
distribut
granular
pattern
high
magnif
color
set
adjust
higher
intens
could
seen
fdx
granul
free
actin
stain
phalloidin
indic
lumen
vesicl
result
shown
interestingli
presenc
iav
moi
uptak
fdx
vesicl
clearli
enhanc
higher
magnif
viral
particl
could
found
coloc
fdx
load
vesicl
well
outsid
vesicl
fig
phalloidin
stain
actin
use
demonstr
mani
viru
particl
local
actinrich
protrus
peripheri
cell
uptak
fdx
studi
quantit
manner
flow
cytometri
fig
c
moder
reproduc
shift
higher
fdx
fluoresc
observ
viru
ad
presenc
fc
wherea
shift
absent
serum
viru
ad
result
confirm
observ
confoc
microscopi
fig
show
combin
presenc
fc
iav
increas
uptak
fdx
compar
fc
alon
control
experi
uptak
fdx
fc
presenc
iav
shown
specif
inhibit
eipa
dynasor
fig
panel
b
contrast
transferrin
uptak
serv
specif
marker
cme
affect
dynasor
eipa
fig
panel
conclus
serum
induc
uptak
fdx
larg
vesicl
enhanc
addit
iav
particl
entri
coloc
part
vesicl
result
indic
util
macropinocyt
pathway
entri
iav
consist
observ
sensit
seruminduc
dynaind
entri
iav
vlp
eipa
macropinocytosi
implic
entri
sever
virus
howev
differ
suscept
inhibitor
suggest
distinct
form
macropinocytosi
might
use
differ
virus
screen
specif
inhibitor
glucentri
assay
use
dynaind
entri
condit
evalu
possibl
involv
signal
cascad
implic
induct
macropinocytosi
seruminduc
macropinocytosi
shown
activ
via
myriad
signal
cascad
initi
growth
factor
bind
transmembran
tyrosin
kinas
receptor
consist
result
shown
fig
promin
downstream
effect
signal
cascad
activ
associ
kinas
turn
activ
number
differ
pathway
lead
actin
network
rearrang
ultim
lead
induct
macropinocytosi
fig
b
show
mm
inhibitor
specif
inhibit
background
fluoresc
fdx
bind
outsid
cell
determin
perform
experi
endocytosi
take
place
subtract
mean
fluoresc
intens
obtain
determin
amount
fluoresc
fitcdextran
intern
data
plot
rel
fitcdextran
uptak
pb
absenc
iav
dynaind
entri
iav
activ
respons
growth
factor
stimul
often
involv
upstream
signal
transduct
member
rho
subfamili
small
gtpase
like
andor
altern
activ
induc
actin
rearrang
independ
direct
interact
wasp
wave
famili
protein
respect
howev
inhibitor
nwasp
wiskostatin
display
inhibitori
effect
dynaind
dynadep
entri
iav
fig
instead
wiskostatin
induc
signific
concentr
depend
increas
entri
stimulatori
effect
observ
control
vaccinia
viru
strain
wr
enter
cell
via
macropinocytot
pathway
fig
indic
effect
specif
iav
result
suggest
requir
dynaind
entri
iav
requir
activ
either
growth
factor
induc
activ
tyrosin
kinas
src
also
link
induct
macropinocytosi
consist
observ
src
inhibitor
specif
inhibit
dynaind
entri
iav
fig
remark
specif
inhibitor
chaperon
protein
also
caus
specif
inhibit
dynaind
entri
fig
affect
fold
activ
mani
protein
recent
demonstr
direct
activ
catalyt
activ
src
provid
anoth
indic
involv
src
dynaind
endocytosi
iav
conclus
like
virus
util
macropinocyt
entri
pathway
seem
play
crucial
role
dynaind
entri
iav
howev
pathway
independ
may
requir
src
either
upstream
andor
downstream
data
present
studi
demonstr
first
time
iav
enter
cell
via
dynaind
macropinocytosi
addit
previous
describ
dynadep
classic
cme
pathway
sever
line
evid
indic
dynaind
entri
rout
iav
identifi
correspond
macropinocytosi
first
entri
pathway
depend
presenc
serum
wellknown
induc
macropinocytosi
second
iav
coloc
vesicl
solubl
fitcdextran
marker
macropinocytosi
third
dynaind
iav
entri
sensit
amiloridederiv
eipa
hallmark
inhibitor
macropinocytosi
fourth
iav
entri
pathway
sensit
inhibitor
dominantneg
mutant
affect
actomyosin
dynam
fifth
specif
inhibit
dynaind
iav
entri
number
inhibitor
growth
factor
receptor
tyrosin
kinas
well
downstream
effector
thereof
also
point
involv
macropinocytosi
final
macropinocytosi
independ
dynamin
despit
extens
list
argument
viral
entri
macropinocytosi
need
consid
caution
characterist
dynaind
rout
cell
entri
iav
similar
ident
macropinocyt
entri
rout
taken
virus
like
two
differ
strain
vaccinia
viru
coxsacki
viru
b
shown
tabl
discuss
detail
macropinocyt
pathway
use
virus
uniqu
characterist
may
well
reflect
grow
notion
macropinocytosi
repres
number
differenti
induc
regul
process
rather
singl
endocyt
pathway
macropinocytosi
collect
describ
induc
form
endocytosi
fluidphas
cargo
travel
via
noncoat
rel
larg
heterogen
organel
eman
extens
protrus
eg
lamellar
ruffl
circular
ruffl
retract
bleb
plasma
membran
case
dynaind
iav
entri
extens
studi
use
electron
microscopi
requir
studi
morpholog
membran
protrus
iav
may
associ
addit
live
cell
imag
microscopi
requir
character
exact
itinerari
taken
iav
virion
travel
via
macropinocyt
process
especi
import
differ
rout
iav
entri
like
converg
point
endocyt
pathway
although
unlik
coloc
iav
particl
fluidphas
dextran
shown
fig
may
thu
repres
situat
occur
converg
sever
differ
rout
use
microscopi
studi
macropinocytosi
howev
complic
lack
specif
membraneassoci
marker
earli
step
endocyt
process
model
fig
base
result
explain
key
step
involv
macropinocyt
entri
pathway
iav
describ
detail
manipul
inocul
condit
abl
experiment
dissect
iav
entri
dynadep
dynaind
rout
dynaind
rout
requir
presenc
fc
entri
assay
medium
previous
strict
depend
dynadep
entri
rout
iav
conclud
experi
cell
line
express
induc
dominantneg
mutant
dynamin
studi
well
entri
studi
iav
entri
perform
dmem
contain
serum
bsa
also
hand
serum
fig
bsa
result
shown
suffici
allow
dynaind
entri
current
investig
serum
compon
respons
observ
effect
iav
entri
dialysi
fc
mw
cut
kda
affect
capac
induc
dynaind
endocytosi
result
shown
indic
low
molecular
weight
solut
respons
observ
effect
evid
dynadep
serum
induc
dynaind
entri
rout
base
use
pharmacolog
dynasor
highli
specif
inhibitor
dynamin
well
genet
sirna
direct
dynamin
tool
rule
possibl
inhibitori
effect
dynasor
due
instanc
absorpt
inhibitor
serum
compon
wherea
dynasor
result
near
inhibit
dynadep
entri
inhibit
observ
upon
sirna
induc
silenc
dynamin
indic
residu
level
dynamin
remain
hr
silenc
still
support
low
level
dynadep
entri
fig
revers
inhibitor
like
dynasor
offer
major
advantag
character
iav
entri
pathway
appli
limit
period
thu
prevent
secondari
adapt
effect
cell
may
occur
respons
longterm
regul
gene
product
genet
method
like
sirna
interfer
entri
rout
consist
identifi
viral
entri
assay
quantifi
viru
induc
express
luciferas
report
well
vlp
entri
assay
allow
direct
analysi
membran
fusion
mediat
entri
step
consist
perform
ha
strict
prefer
bind
link
sialic
acid
iavwsn
unpublish
data
ha
also
bind
link
sialic
acid
iav
vlp
entri
assay
indic
pathway
util
differ
specif
may
therefor
relev
avian
well
human
iav
infect
consist
seruminduc
dynaind
entri
observ
avian
cell
human
lung
epitheli
carcinoma
cell
line
fig
dynadep
dynaind
iav
entri
pathway
found
quantit
assay
fulli
redund
presenc
serum
combin
dynasor
inhibit
dynadep
entri
eipa
inhibit
dynaind
entri
complet
abolish
entri
wherea
either
drug
alon
effect
eipa
inhibitor
plasma
membran
nah
exchang
shown
invari
inhibit
macropinocytosi
rout
endocytosi
gener
affect
eipa
consid
hallmark
inhibitor
macropinocytosi
although
result
obtain
eipa
consid
care
long
mechanist
explan
effect
macropinocytosi
yet
fulli
clear
occasion
moder
twoto
threefold
inhibit
dynasor
alon
observ
result
shown
indic
capac
seruminduc
entri
pathway
somewhat
variabl
possibl
depend
slight
variat
serum
qualiti
factor
like
cell
distribut
well
report
influenc
viral
infect
redund
util
cme
well
clathrinindepend
rout
entri
iav
visual
previous
quantit
live
cell
imag
rout
oper
simultan
sampl
specif
downregul
cme
affect
total
number
entri
event
respons
specif
extracellular
signal
eg
serum
induct
chang
actomyosin
network
occur
give
rise
membran
protrus
requir
macropinosom
format
compound
inhibit
actin
polymer
cytochalasin
b
depolymer
jasplakinolid
sequest
solubl
actin
latrunculin
specif
inhibit
dynaind
iav
entri
addit
requir
myosinii
activ
establish
specif
inhibitor
blebbistatin
myosin
ii
atpas
activ
express
domin
neg
mutant
myosiniia
heavi
chain
also
regul
myosinii
activ
phosphoryl
myosin
light
chain
action
mlck
suggest
inhibitori
effect
mlck
inhibitor
well
similar
effect
express
mlck
domin
neg
mutant
recent
function
actin
cytoskeleton
iav
entri
report
requir
entri
polar
epitheli
cell
entri
nonpolar
cell
use
lowserum
condit
use
paper
fc
observ
dynadep
entri
affect
actin
dynam
inhibitor
perhap
polar
cell
permit
dynaind
entri
lower
serum
concentr
chang
actin
network
dynam
lead
format
macropinosom
trigger
number
signal
cascad
actin
dynam
induc
activ
growth
factor
receptor
tyrosin
kinas
respect
figur
model
iav
entri
macropinocytosi
model
summar
inhibitori
red
box
stimulatori
blue
box
effect
compound
dynaminindepend
iav
entri
effect
overexpress
dominantneg
mutant
indic
redlin
box
pathway
requir
presenc
serum
factor
entri
medium
result
enhanc
uptak
dextran
coloc
iav
larg
vesicl
green
box
hypothes
interact
serum
factor
andor
iav
receptor
tyrosin
kinas
rtk
primari
signal
induct
macropinocytosi
number
rtk
shown
involv
process
differ
cell
line
remark
recent
publish
genomewid
sirna
screen
iav
infect
identifi
fgf
receptor
host
factor
requir
influenza
viru
replic
activ
rho
famili
gtpase
andor
shown
essenti
signal
transduct
lead
macropinocytosi
mani
case
inhibitor
without
effect
stimulatori
case
iav
entri
downstream
effector
rho
famili
gtpase
includ
scaffold
protein
like
nwasp
wave
protein
kinas
like
macropinocyt
entri
iav
howev
seem
requir
rho
famili
gtpaseindepend
activ
mechan
addit
src
famili
kinas
directli
activ
rtk
play
role
src
previous
link
activ
macropinocytosi
via
effect
chang
actomyosin
dynam
process
crucial
form
macropinosom
format
apart
nwaspor
wavecontain
macromolecular
assembl
actin
bind
protein
induc
chang
eg
cortactin
activ
src
therebi
induc
format
one
differ
plasma
membran
protrus
result
format
macropinosom
addit
effect
format
plasma
membran
protrus
subsequ
macropinosom
format
inhibitor
also
affect
downstream
traffick
matur
macropinosom
might
actindepend
depict
scheme
growth
factor
ligand
normal
present
serum
signal
transduct
cascad
link
activ
growth
factor
receptor
tyrosin
kinas
actin
remodel
macropinocytosi
begin
reveal
specif
inhibit
dynaind
entri
iav
inhibitor
provid
proof
involv
cascad
key
serinethreonin
kinas
regul
actin
network
dynam
crucial
function
sever
pathway
endocytosi
well
numer
cellular
process
make
specif
marker
even
macropinocytosi
consist
demonstr
requir
activ
induct
process
andor
downstream
traffick
event
macropinosom
growth
factor
depend
activ
often
demonstr
depend
upstream
activ
small
gtpase
differ
strain
vaccinia
viru
recent
shown
induc
uptak
macropinocytosi
via
activ
either
activ
link
induct
macropinocytosi
via
actin
networkmedi
format
lamellipodia
andor
circular
ruffl
wherea
often
impli
format
filopodia
inhibitori
effect
inhibitor
inhibitor
iav
entri
howev
could
demonstr
remark
inhibitor
enhanc
iav
entri
similar
effect
observ
wiskostatin
inhibitor
nwasp
function
directli
downstream
scaffold
complex
requir
activ
actin
polymer
lead
filopodia
format
similarli
macropinocytosislik
entri
pathway
taken
coxsacki
b
viru
also
shown
requir
activ
independ
activ
direct
examin
magnitud
time
activ
requir
obtain
insight
involv
complex
pathway
induct
macropinocytosi
mechan
associ
ruffl
cell
membran
identif
submembran
region
increas
actin
stain
phalloidin
interpret
evid
ruffl
unambigu
identifi
confoc
microscopi
experi
present
fig
fig
need
investig
depth
life
cell
imag
techniqu
agreement
observ
dynaind
entri
iav
inhibit
inhibitor
src
famili
kinas
nonreceptor
tyrosin
kinas
csrc
shown
function
key
signal
intermedi
induct
macropinocytosi
via
mechan
independ
downstream
effect
csrc
actin
network
proceed
amongst
other
via
phosphoryl
cortactin
csrc
result
acceler
macropinosom
format
csrc
shown
associ
macropinosom
format
traffick
csrc
kinas
activ
requir
macropinocytosi
follow
egf
stimul
hela
cell
interact
csrc
recent
shown
induc
csrc
kinas
activ
also
demonstr
associ
macropinosom
specif
inhibitor
geldanamycin
reduc
membran
ruffl
preced
macropinocytosi
thu
inhibit
iav
entri
via
macropinocytosi
aageldanamcyin
may
well
involv
effect
csrc
detail
dynaind
entri
pathway
iav
share
mani
characterist
endocyt
pathway
macropinocytosi
corrobor
observ
iav
particl
dextran
coloc
larg
vesicl
presenc
fc
sever
virus
recent
report
enter
cell
via
macropinocytosi
apart
common
factor
like
requir
activ
actin
dynam
independ
dynamin
viru
specif
detail
describ
tabl
part
might
contribut
differ
experiment
condit
eg
cell
type
test
divers
molecular
mechan
macropinocytosi
induc
execut
like
exist
exploit
virus
wherea
vaccinia
viru
abl
trigger
macropinocyt
uptak
describ
macropinocytosi
pathway
oper
condit
activ
compon
serum
still
exclud
signal
induc
virushost
cell
interact
instanc
suggest
signific
increas
fitcdextran
uptak
presenc
iav
possibl
requir
costimulatori
signal
serum
compon
viru
impos
addit
layer
complex
analysi
iav
entri
via
dynaind
pathway
influenza
virus
caus
respiratori
infect
target
epitheli
cell
line
respiratori
tract
surfac
cover
mucou
layer
compos
varieti
small
solut
glycoprotein
deriv
among
other
goblet
cell
semifluid
layer
turn
condit
underli
cell
determin
physiolog
state
includ
activ
uptak
secret
pathway
import
determin
extent
dynadep
dynaind
iav
entri
pathway
oper
condit
prevail
along
respiratori
tract
current
knowledg
protein
composit
fluid
cover
respiratori
epithelium
rapidli
expand
applic
proteom
method
determin
protein
composit
bronchial
alveolar
lavag
fluid
balf
studi
extend
previou
notion
balf
highli
similar
composit
serum
exampl
serum
proteom
total
protein
mass
balf
proteom
account
albumin
immunoglobulin
transfer
haptoglobin
addit
mani
protein
identifi
serum
balf
includ
growth
factor
bind
growth
factor
receptor
tyrosin
kinas
thu
balf
like
harbor
serum
protein
factor
activ
signal
pathway
crucial
induct
dynaind
entri
iav
agreement
herewith
macropinocytosi
describ
function
entri
pathway
haemophilu
influenza
primari
human
bronchial
epitheli
cell
although
factor
involv
signal
process
identifi
yet
addit
infect
respiratori
tract
iav
shown
abl
caus
system
infect
involv
multipl
organ
mainli
studi
avian
infect
infect
mice
humanderiv
iav
poorli
document
human
infect
may
underestim
thu
far
obvious
potenti
system
spread
iav
serumrich
condit
demonstr
enabl
use
altern
entri
pathway
encount
may
contribut
spread
mdck
hela
cell
maintain
complet
dulbecco
modifi
eagl
medium
dmem
lonza
biowittak
contain
vv
fetal
calf
serum
fc
bodinco
bv
uml
penicillin
mgml
streptomycin
chines
cell
maintain
aminim
essenti
medium
gibco
supplement
vv
fc
uml
penicillin
mgml
streptomycin
cell
passag
twice
weekli
influenza
iavwsn
grown
mdck
cell
briefli
confluent
mdck
cell
infect
iavwsn
moi
supernat
harvest
hr
incub
cell
debri
remov
centrifigut
min
rpm
viru
store
viru
titer
determin
measur
tcid
hela
cell
iavwsn
luciferas
pseudoviru
wsnren
system
previous
describ
briefli
wsnren
pseudoviru
harbor
ha
segment
ha
code
region
replac
renilla
luciferas
pseudoviru
produc
mdck
cell
line
stabli
express
ha
iavwsn
wrluc
firefli
luciferas
encod
vaccinia
viru
strain
wr
previous
describ
vsvfl
firefli
luciferas
encod
vsv
viru
also
previous
describ
stock
bafilomycin
dynasor
cytochalasin
cytochalasin
b
blebbistatin
nethylnisopropyl
amilorid
eipa
obtain
sigmaaldrich
latrunculin
enzo
jasplakinolid
wiskostatin
obtain
calbiochem
chembridg
prepar
dimethylsulfoxid
dmso
stock
store
kinas
inhibitor
librari
compos
kinas
inhibitor
obtain
biomol
hela
cell
cellswel
plate
treat
munit
vibrio
cholera
neuraminidas
roch
ml
phosphatebuff
salin
pb
hr
wash
pb
cell
infect
iav
describ
viruslik
particl
vlp
produc
describ
briefli
cell
transfect
use
lipofectamin
invitrogen
encod
betalactamas
report
protein
fuse
influenza
matrix
pcaggsha
encod
ha
deriv
either
anewyork
iavwsn
pcaggsna
encod
iav
neuraminidas
na
deriv
either
iavwsn
maintain
optimem
supernat
harvest
h
transfect
centrifug
remov
debri
vlp
use
inocul
cell
without
concentr
vlp
incub
min
trypsintpck
activ
ha
mdck
hela
cell
grown
near
confluenc
plate
inocul
ul
vlp
pretreat
cell
inhibitor
indic
infect
synchron
centrifug
rpm
min
perform
incub
h
absenc
presenc
fc
inhibitor
indic
detect
betalactamas
activ
perform
describ
load
cell
substrat
invitrogen
subsequ
analysi
flow
cytometri
lsrii
flow
cytomet
becton
dickinson
typic
event
collect
analyz
use
flowjo
softwar
report
construct
phhgluc
deriv
plasmid
phhfluc
replac
firefli
luciferas
code
region
gaussia
luciferas
code
region
pglucbas
new
england
biolab
uniqu
spei
xbai
restrict
site
introduc
phhfluc
use
quikchang
xl
sitedirect
mutagenesi
kit
stratagen
oligonucleotid
ccaagaagggcggaaagtctagattgtaaagaaaaatac
spei
site
introduc
sitedirect
mutagenesi
pglucbas
directli
follow
start
codon
gaussia
luciferas
code
sequenc
uniqu
spei
xbai
fragment
pglucbas
subsequ
clone
speixbai
site
phhfluc
result
plasmid
phhgluc
cell
seed
plate
densiti
cell
well
transfect
next
day
ng
phhgluc
use
lipofectamin
invitrogen
accord
manufactur
protocol
hr
transfect
cell
treat
inhibitor
infect
indic
hr
pi
sampl
supernat
assay
luciferas
activ
use
renilla
luciferas
assay
system
promega
accord
manufactur
instruct
rel
light
unit
rlu
determin
berthold
centro
lb
plate
luminomet
wrluc
vsvfl
use
inocul
hela
cell
cellswel
moi
complet
dulbecco
modifi
eagl
medium
dmem
lonza
biowittak
hr
luciferas
activ
detect
use
steadyglo
assay
kit
promega
addit
vv
fc
chang
infect
level
virus
cell
fix
paraformaldehyd
pfa
pb
subsequ
permeabil
pb
block
normal
goat
serum
iavinfect
cell
incub
h
monoclon
antibodi
direct
nucleoprotein
np
kindli
provid
dr
ben
peeter
wash
cell
incub
dilut
alexa
fluor
goat
antimous
igg
molecular
probe
secondari
antibodi
h
nuclei
subsequ
stain
three
wash
step
coverslip
mount
fluorsav
calbiochem
actin
stain
use
phalloidin
label
alexa
fluor
immunofluoresc
stain
analyz
use
confoc
laserscan
microscop
leica
tc
fitc
gfp
alexa
fluor
excit
nm
alexa
fluor
nm
nm
hela
cell
grown
plate
glass
coverslip
cellswel
prior
fitcdextran
uptak
cell
serumstarv
hr
pb
fitcdextran
sigmaaldrich
incub
hela
cell
final
concentr
mgml
ml
pb
pb
contain
fc
absenc
presenc
iav
strain
wsn
moi
concentr
purifi
centrifug
sucros
gradient
sucros
cushion
bottom
min
cell
wash
time
pb
fix
pfa
pb
subsequ
permeabil
pb
slide
stain
examin
confoc
microscopi
describ
quantif
fitcdextran
uptak
hela
cell
infect
iavwsn
moi
suspens
volum
ml
presenc
fitcdextran
mgml
infect
perform
min
pb
contain
bsa
reduc
unspecif
bind
fitcdextran
pb
contain
fc
control
bind
fitcdextran
cell
absenc
endocytosi
mockinfect
sampl
analys
parallel
infect
termin
addit
ml
icecold
pb
follow
three
wash
cold
pb
fixat
pfa
cell
analyz
fac
result
repres
mean
fluoresc
plot
rel
uptak
mockinfect
pb
subtract
background
fluoresc
obtain
effect
dynasor
eipa
dextran
transferrin
uptak
hela
cell
grown
glass
cover
slip
incub
hr
mgml
transferin
invitrogen
pb
hr
medium
replac
pb
pb
supplement
fc
contain
iav
strain
wsn
moi
mgml
fitcdextran
sigma
kda
cell
transfer
min
min
cell
fix
stain
describ
examin
confoc
microscopi
cell
fix
pfa
pb
subsequ
permeabil
pb
peroxidas
visual
use
aec
substrat
kit
vector
laboratori
iavposit
cell
detect
use
brightfield
light
microscopi
two
sirna
duplex
target
differ
site
within
code
sequenc
dynamin
obtain
ambion
inc
dynamin
sirna
dynamin
scrambl
sirna
ambion
inc
taken
along
control
nonspecif
effect
transfect
procedur
use
normal
one
day
seed
plate
cellswel
hela
cell
transfect
final
concentr
nm
sirna
use
oligofectamin
invitrogen
h
transfect
cell
inocul
wsnren
pseudoviru
moi
pb
pb
contain
fc
h
infect
entri
medium
replac
complet
growth
medium
contain
nm
prevent
entri
h
post
infect
intracellular
renilla
luciferas
express
determin
describ
sirna
experi
perform
triplic
cell
viabil
affect
determin
perform
cellviabl
assay
roch
function
knockdown
dynamin
mrna
level
perform
quantit
rtpcr
use
taqman
gene
express
assay
ambion
use
rna
ambion
control
normal
compar
ctmethod
use
quantif
result
reduct
dynamin
protein
level
determin
western
blot
use
polyclon
goatantidynamin
santacruz
monoclon
alphatubulin
sigma
use
detect
tubulin
normal
result
quantifi
densitometr
scan
dynamin
tubulin
signal
display
fig
hela
cell
grown
plate
glass
coverslip
cellswel
hr
cell
transfect
mg
dna
lipofectamin
describ
plasmid
encod
wildtyp
dominantneg
dn
human
mlck
fuse
gfp
wildtyp
dn
fuse
gfp
myoiitail
myoiihead
domain
fuse
gfp
hr
transfect
cell
inocul
iavwsn
moi
pb
pb
contain
fc
mm
dynasor
hr
infect
cell
fix
stain
examin
confoc
microscopi
describ
unpair
student
ttest
use
detemin
statist
signific
differ
use
term
signific
text
refer
comparison
valu
